FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

CBER Updates Process for Formal Disputes With Sponsors

CBER updates its standard operating procedures for resolving scientific/procedural disputes between sponsors and the Center, establishing revised proc...

latest-news-card-1
Human Drugs

FDA Issues New Guidance on Therapeutic Equivalence Evaluations

FDA issues a final guidance describing how it evaluates therapeutic equivalence among prescription drug products and assigns therapeutic equivalence c...

latest-news-card-1
Medical Devices

Early Alert on : GE HealthCare Portrait Core Monitor Software

CDRH issues an Early Alert after becoming aware that GE HealthCare sent a letter alerting affected customers of updated use instructions for Portrait ...

latest-news-card-1
Medical Devices

Boston Scientific Recalls ENROUTE Percutaneous Catheter Kit

Boston Scientific recalls its ENROUTE Transcarotid Neuroprotection System Plus, a single-use percutaneous catheter kit used during transcarotid artery...

latest-news-card-1
FDA General

Commissioner Pick Faces Potentially Lengthy Senate Confirmation

Senate confirmation of FDA commissioner nominee Heidi Overton appears to be getting some resistance and a quick Senate confirmation seems unlikely.

latest-news-card-1
Medical Devices

Digital Health Technologies Capture Real-Time Info: Column

FDA Digital Health Center of Excellence director Rick Abramson outlines an agency white paper on developing and using digitally derived measures in cl...

latest-news-card-1
Medical Devices

Medline Convenience Kit Recall is Class 1

Medline issues a device correction (Class 1 recall) for convenience kits containing B. Brauns bupivacaine hydrochloride components.

latest-news-card-1
Human Drugs

4 Observations in Suretec Inspection

FDA warns Gilbert, AZ-based Suretec Innovations about CGMP and drug listing violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

FDA Issues Complete Response Letter for Xspray Pharmas Dasynoc

FDA issues a complete response letter to Xspray Pharmas NDA for Dasynoc, raising issues about a third-party manufacturer.

latest-news-card-1
Human Drugs

Ultragenyx Gene Therapy OKd for Glycogen Storage Disease

FDA grants Ultragenyx Pharmaceutical accelerated approval for its Genglycos (pariglasgene brecaparvovec-opnr) for adults and children eight years and ...